Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test
A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict…
16/09/2019 - 3 minutes
Infectious disease
Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
20/08/2019 - 3 minutes
First Potential Chlamydia Vaccine Shows Early Promise
A vaccine targeting the sexually transmitted infection chlamydia, which would be the first of its…
16/08/2019 - 3 minutes
Ultra-Fast Diagnostics Could Transform Sexual Health
Each day more than one million people around the world acquire sexually transmitted infections, with…
04/06/2019 - 7 minutes
European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?
We spend a lot of time focusing on specific developments in biotechnology, but sometimes it's…
25/04/2019 - 11 minutes
Flu Resistant to Antivirals? This Biotech Has a Drug for That
We are visiting the medieval German city of Tübingen this week. It hosts the biotech…
08/03/2019 - 3 minutes
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
01/03/2019 - 3 minutes
Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin
A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its…
18/02/2019 - 3 minutes
Llama Antibodies Could Be the Key to Universal Flu Prevention
Researchers have developed a new approach to prevent the flu that can protect against all…
01/11/2018 - 3 minutes
Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?
Despite more than a century of scientific endeavour, influenza remains one of the most deadly…
01/10/2018 - 8 minutes
Update: Seaweed-Derived Treatment for Common Cold Approved in the EU
Update (07/08/2018): Marinomed Biotech has obtained EU approval to sell a nasal spray containing a…
07/08/2018 - 2 minutes
London Biotech Raises €47M to Develop First Treatment Against RSV Virus
ReViral will dedicate the funds to run two clinical trials to test whether its antiviral…
01/08/2018 - 2 minutes
